Sign in
8-K

Current Report

Foghorn Therapeutics Inc. Filed Acc 0001628280-22-009351

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading fhtx-20220415.htm…